PUBLISHER: TechNavio | PRODUCT CODE: 1076925
PUBLISHER: TechNavio | PRODUCT CODE: 1076925
Technavio has been monitoring the nucleic acid amplification market and it is poised to grow by $ 1.47 bn during 2022-2026, accelerating at a CAGR of 7.73% during the forecast period. Our report on the nucleic acid amplification market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing research and development (R&D) activities at academic institutes and medical organizations, increasing prevalence of infectious diseases, and increasing demand for advanced diagnostic measures.
The nucleic acid amplification market analysis includes technique segment and geographic landscape.
Technavio's nucleic acid amplification market is segmented as below:
By Technique
By Geographical Landscape
This study identifies the increasing investment in the development of new biotechnological techniques as one of the prime reasons driving the nucleic acid amplification market growth during the next few years. Also, technological advances in the life sciences industry and an increasing number of applications of molecular biology will lead to sizable demand in the market.
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading nucleic acid amplification market vendors that include Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, Danaher Corp., Eiken Chemical Co. Ltd., F. Hoffmann La Roche Ltd., Grifols SA, Hologic Inc., Illumina Inc., LGC Ltd., Meridian Bioscience Inc., New England Biolabs Inc., Novartis AG, OptiGene Ltd., Promega Corp., Quidel Corp., Siemens AG, Tecan Group Ltd., Thermo Fisher Scientific Inc., and Ustar Biotechnologies Hangzhou Ltd. . Also, the nucleic acid amplification market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: